PUBLISHER: TechNavio | PRODUCT CODE: 1657210

PUBLISHER: TechNavio | PRODUCT CODE: 1657210

Global Urea Cycle Disorder Treatment Market 2025-2029

PUBLISHED: February 8, 2025

PAGES: 209 Pages

DELIVERY TIME: 1-2 business days

SELECT AN OPTION

The urea cycle disorder treatment market is forecasted to grow by USD 227.4 million during 2024-2029, accelerating at a CAGR of 3.3% during the forecast period. The report on the urea cycle disorder treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of urea cycle disorder, rising geriatric patients, and rising focus on strategic initiatives.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	3.1%
CAGR	3.3%
Incremental Value	$227.4 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's urea cycle disorder treatment market is segmented as below:

By Therapy

Glycerol phenylbutyrate
Sodium phenylbutyrate
Amino acid supplements
Sodium benzoate
Others

By Route Of Administration

Oral
Injectables

By End-user

Hospitals
Specialized clinics
Home care settings
Research institutions

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing growth potential in emerging economies as one of the prime reasons driving the urea cycle disorder treatment market growth during the next few years. Also, increasing technological advancements in terms of early screening and diagnosis and growing need for companion diagnostics in treatment of UCD will lead to sizable demand in the market.

The report on the urea cycle disorder treatment market covers the following areas:

Urea Cycle Disorder Treatment Market sizing
Urea Cycle Disorder Treatment Market forecast
Urea Cycle Disorder Treatment Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading urea cycle disorder treatment market vendors that include Abbott Laboratories, Acer Therapeutics Inc., Arcturus Therapeutics Holdings Inc., Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, CAMP4, Dipharma SA, Eurocept B.V., Horizon Therapeutics PLC, Immedica Pharma AB, Medunik USA, Nestle SA, Orpharma Pty Ltd., Reckitt Benckiser Group PLC, Recordati S.p.A, RELIEF THERAPEUTICS Holding SA, Spyre Therapeutics Inc., Swedish Orphan Biovitrum AB, Synlogic Inc., and Ultragenyx Pharmaceutical Inc.. Also, the urea cycle disorder treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR75899

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Therapy
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Urea Cycle Disorder Treatment Market 2019 - 2023
- Historic Market Size - Data Table on Global Urea Cycle Disorder Treatment Market 2019 - 2023 ($ million)
5.2 Therapy segment analysis 2019 - 2023
- Historic Market Size - Therapy Segment 2019 - 2023 ($ million)
5.3 Route of Administration segment analysis 2019 - 2023
- Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
5.4 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 Impact of AI on Global Urea Cycle Disorder Treatment Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Therapy

8.1 Market segments
- Chart on Therapy - Market share 2024-2029 (%)
- Data Table on Therapy - Market share 2024-2029 (%)
8.2 Comparison by Therapy
- Chart on Comparison by Therapy
- Data Table on Comparison by Therapy
8.3 Glycerol phenylbutyrate - Market size and forecast 2024-2029
- Chart on Glycerol phenylbutyrate - Market size and forecast 2024-2029 ($ million)
- Data Table on Glycerol phenylbutyrate - Market size and forecast 2024-2029 ($ million)
- Chart on Glycerol phenylbutyrate - Year-over-year growth 2024-2029 (%)
- Data Table on Glycerol phenylbutyrate - Year-over-year growth 2024-2029 (%)
8.4 Sodium phenylbutyrate - Market size and forecast 2024-2029
- Chart on Sodium phenylbutyrate - Market size and forecast 2024-2029 ($ million)
- Data Table on Sodium phenylbutyrate - Market size and forecast 2024-2029 ($ million)
- Chart on Sodium phenylbutyrate - Year-over-year growth 2024-2029 (%)
- Data Table on Sodium phenylbutyrate - Year-over-year growth 2024-2029 (%)
8.5 Amino acid supplements - Market size and forecast 2024-2029
- Chart on Amino acid supplements - Market size and forecast 2024-2029 ($ million)
- Data Table on Amino acid supplements - Market size and forecast 2024-2029 ($ million)
- Chart on Amino acid supplements - Year-over-year growth 2024-2029 (%)
- Data Table on Amino acid supplements - Year-over-year growth 2024-2029 (%)
8.6 Sodium benzoate - Market size and forecast 2024-2029
- Chart on Sodium benzoate - Market size and forecast 2024-2029 ($ million)
- Data Table on Sodium benzoate - Market size and forecast 2024-2029 ($ million)
- Chart on Sodium benzoate - Year-over-year growth 2024-2029 (%)
- Data Table on Sodium benzoate - Year-over-year growth 2024-2029 (%)
8.7 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
8.8 Market opportunity by Therapy
- Market opportunity by Therapy ($ million)
- Data Table on Market opportunity by Therapy ($ million)

9 Market Segmentation by Route of Administration

9.1 Market segments
- Chart on Route of Administration - Market share 2024-2029 (%)
- Data Table on Route of Administration - Market share 2024-2029 (%)
9.2 Comparison by Route of Administration
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
9.3 Oral - Market size and forecast 2024-2029
- Chart on Oral - Market size and forecast 2024-2029 ($ million)
- Data Table on Oral - Market size and forecast 2024-2029 ($ million)
- Chart on Oral - Year-over-year growth 2024-2029 (%)
- Data Table on Oral - Year-over-year growth 2024-2029 (%)
9.4 Injectables - Market size and forecast 2024-2029
- Chart on Injectables - Market size and forecast 2024-2029 ($ million)
- Data Table on Injectables - Market size and forecast 2024-2029 ($ million)
- Chart on Injectables - Year-over-year growth 2024-2029 (%)
- Data Table on Injectables - Year-over-year growth 2024-2029 (%)
9.5 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)

10 Market Segmentation by End-user

10.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
10.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
10.3 Hospitals - Market size and forecast 2024-2029
- Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
- Chart on Hospitals - Year-over-year growth 2024-2029 (%)
- Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
10.4 Specialized clinics - Market size and forecast 2024-2029
- Chart on Specialized clinics - Market size and forecast 2024-2029 ($ million)
- Data Table on Specialized clinics - Market size and forecast 2024-2029 ($ million)
- Chart on Specialized clinics - Year-over-year growth 2024-2029 (%)
- Data Table on Specialized clinics - Year-over-year growth 2024-2029 (%)
10.5 Home care settings - Market size and forecast 2024-2029
- Chart on Home care settings - Market size and forecast 2024-2029 ($ million)
- Data Table on Home care settings - Market size and forecast 2024-2029 ($ million)
- Chart on Home care settings - Year-over-year growth 2024-2029 (%)
- Data Table on Home care settings - Year-over-year growth 2024-2029 (%)
10.6 Research institutions - Market size and forecast 2024-2029
- Chart on Research institutions - Market size and forecast 2024-2029 ($ million)
- Data Table on Research institutions - Market size and forecast 2024-2029 ($ million)
- Chart on Research institutions - Year-over-year growth 2024-2029 (%)
- Data Table on Research institutions - Year-over-year growth 2024-2029 (%)
10.7 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.9 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
12.10 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.11 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.12 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
12.13 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
12.14 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
12.15 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.16 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
15.5 Acer Therapeutics Inc.
- Acer Therapeutics Inc. - Overview
- Acer Therapeutics Inc. - Product / Service
- Acer Therapeutics Inc. - Key offerings
- SWOT
15.6 Arcturus Therapeutics Holdings Inc.
- Arcturus Therapeutics Holdings Inc. - Overview
- Arcturus Therapeutics Holdings Inc. - Product / Service
- Arcturus Therapeutics Holdings Inc. - Key offerings
- SWOT
15.7 Bausch Health Companies Inc.
- Bausch Health Companies Inc. - Overview
- Bausch Health Companies Inc. - Business segments
- Bausch Health Companies Inc. - Key news
- Bausch Health Companies Inc. - Key offerings
- Bausch Health Companies Inc. - Segment focus
- SWOT
15.8 Boehringer Ingelheim International GmbH
- Boehringer Ingelheim International GmbH - Overview
- Boehringer Ingelheim International GmbH - Product / Service
- Boehringer Ingelheim International GmbH - Key news
- Boehringer Ingelheim International GmbH - Key offerings
- SWOT
15.9 CAMP4
- CAMP4 - Overview
- CAMP4 - Product / Service
- CAMP4 - Key offerings
- SWOT
15.10 Eurocept B.V.
- Eurocept B.V. - Overview
- Eurocept B.V. - Product / Service
- Eurocept B.V. - Key offerings
- SWOT
15.11 Horizon Therapeutics Plc
- Horizon Therapeutics Plc - Overview
- Horizon Therapeutics Plc - Product / Service
- Horizon Therapeutics Plc - Key offerings
- SWOT
15.12 Medunik USA
- Medunik USA - Overview
- Medunik USA - Product / Service
- Medunik USA - Key offerings
- SWOT
15.13 Orpharma Pty Ltd.
- Orpharma Pty Ltd. - Overview
- Orpharma Pty Ltd. - Product / Service
- Orpharma Pty Ltd. - Key offerings
- SWOT
15.14 Recordati S.p.A
- Recordati S.p.A - Overview
- Recordati S.p.A - Business segments
- Recordati S.p.A - Key offerings
- Recordati S.p.A - Segment focus
- SWOT
15.15 RELIEF THERAPEUTICS Holding SA
- RELIEF THERAPEUTICS Holding SA - Overview
- RELIEF THERAPEUTICS Holding SA - Product / Service
- RELIEF THERAPEUTICS Holding SA - Key offerings
- SWOT
15.16 Spyre Therapeutics Inc.
- Spyre Therapeutics Inc. - Overview
- Spyre Therapeutics Inc. - Product / Service
- Spyre Therapeutics Inc. - Key offerings
- SWOT
15.17 Synlogic Inc.
- Synlogic Inc. - Overview
- Synlogic Inc. - Product / Service
- Synlogic Inc. - Key offerings
- SWOT
15.18 Ultragenyx Pharmaceutical Inc.
- Ultragenyx Pharmaceutical Inc. - Overview
- Ultragenyx Pharmaceutical Inc. - Product / Service
- Ultragenyx Pharmaceutical Inc. - Key offerings
- SWOT

16 Appendix

16.1 Scope of the report
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations

Product Code: IRTNTR75899

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits7: Executive Summary - Chart on Market Segmentation by End-user
Exhibits8: Executive Summary - Chart on Incremental Growth
Exhibits9: Executive Summary - Data Table on Incremental Growth
Exhibits10: Executive Summary - Chart on Company Market Positioning
Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits12: Overview on criticality of inputs and factors of differentiation
Exhibits13: Overview on factors of disruption
Exhibits14: Impact of drivers and challenges in 2024 and 2029
Exhibits15: Parent Market
Exhibits16: Data Table on - Parent Market
Exhibits17: Market characteristics analysis
Exhibits18: Value chain analysis
Exhibits19: Offerings of companies included in the market definition
Exhibits20: Market segments
Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits25: Historic Market Size - Data Table on Global Urea Cycle Disorder Treatment Market 2019 - 2023 ($ million)
Exhibits26: Historic Market Size - Therapy Segment 2019 - 2023 ($ million)
Exhibits27: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
Exhibits28: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits31: Five forces analysis - Comparison between 2024 and 2029
Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits37: Chart on Market condition - Five forces 2024 and 2029
Exhibits38: Chart on Therapy - Market share 2024-2029 (%)
Exhibits39: Data Table on Therapy - Market share 2024-2029 (%)
Exhibits40: Chart on Comparison by Therapy
Exhibits41: Data Table on Comparison by Therapy
Exhibits42: Chart on Glycerol phenylbutyrate - Market size and forecast 2024-2029 ($ million)
Exhibits43: Data Table on Glycerol phenylbutyrate - Market size and forecast 2024-2029 ($ million)
Exhibits44: Chart on Glycerol phenylbutyrate - Year-over-year growth 2024-2029 (%)
Exhibits45: Data Table on Glycerol phenylbutyrate - Year-over-year growth 2024-2029 (%)
Exhibits46: Chart on Sodium phenylbutyrate - Market size and forecast 2024-2029 ($ million)
Exhibits47: Data Table on Sodium phenylbutyrate - Market size and forecast 2024-2029 ($ million)
Exhibits48: Chart on Sodium phenylbutyrate - Year-over-year growth 2024-2029 (%)
Exhibits49: Data Table on Sodium phenylbutyrate - Year-over-year growth 2024-2029 (%)
Exhibits50: Chart on Amino acid supplements - Market size and forecast 2024-2029 ($ million)
Exhibits51: Data Table on Amino acid supplements - Market size and forecast 2024-2029 ($ million)
Exhibits52: Chart on Amino acid supplements - Year-over-year growth 2024-2029 (%)
Exhibits53: Data Table on Amino acid supplements - Year-over-year growth 2024-2029 (%)
Exhibits54: Chart on Sodium benzoate - Market size and forecast 2024-2029 ($ million)
Exhibits55: Data Table on Sodium benzoate - Market size and forecast 2024-2029 ($ million)
Exhibits56: Chart on Sodium benzoate - Year-over-year growth 2024-2029 (%)
Exhibits57: Data Table on Sodium benzoate - Year-over-year growth 2024-2029 (%)
Exhibits58: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits59: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits60: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits61: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits62: Market opportunity by Therapy ($ million)
Exhibits63: Data Table on Market opportunity by Therapy ($ million)
Exhibits64: Chart on Route of Administration - Market share 2024-2029 (%)
Exhibits65: Data Table on Route of Administration - Market share 2024-2029 (%)
Exhibits66: Chart on Comparison by Route of Administration
Exhibits67: Data Table on Comparison by Route of Administration
Exhibits68: Chart on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits69: Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits70: Chart on Oral - Year-over-year growth 2024-2029 (%)
Exhibits71: Data Table on Oral - Year-over-year growth 2024-2029 (%)
Exhibits72: Chart on Injectables - Market size and forecast 2024-2029 ($ million)
Exhibits73: Data Table on Injectables - Market size and forecast 2024-2029 ($ million)
Exhibits74: Chart on Injectables - Year-over-year growth 2024-2029 (%)
Exhibits75: Data Table on Injectables - Year-over-year growth 2024-2029 (%)
Exhibits76: Market opportunity by Route of Administration ($ million)
Exhibits77: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits78: Chart on End-user - Market share 2024-2029 (%)
Exhibits79: Data Table on End-user - Market share 2024-2029 (%)
Exhibits80: Chart on Comparison by End-user
Exhibits81: Data Table on Comparison by End-user
Exhibits82: Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibits83: Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibits84: Chart on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibits85: Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibits86: Chart on Specialized clinics - Market size and forecast 2024-2029 ($ million)
Exhibits87: Data Table on Specialized clinics - Market size and forecast 2024-2029 ($ million)
Exhibits88: Chart on Specialized clinics - Year-over-year growth 2024-2029 (%)
Exhibits89: Data Table on Specialized clinics - Year-over-year growth 2024-2029 (%)
Exhibits90: Chart on Home care settings - Market size and forecast 2024-2029 ($ million)
Exhibits91: Data Table on Home care settings - Market size and forecast 2024-2029 ($ million)
Exhibits92: Chart on Home care settings - Year-over-year growth 2024-2029 (%)
Exhibits93: Data Table on Home care settings - Year-over-year growth 2024-2029 (%)
Exhibits94: Chart on Research institutions - Market size and forecast 2024-2029 ($ million)
Exhibits95: Data Table on Research institutions - Market size and forecast 2024-2029 ($ million)
Exhibits96: Chart on Research institutions - Year-over-year growth 2024-2029 (%)
Exhibits97: Data Table on Research institutions - Year-over-year growth 2024-2029 (%)
Exhibits98: Market opportunity by End-user ($ million)
Exhibits99: Data Table on Market opportunity by End-user ($ million)
Exhibits100: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits101: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits102: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits103: Chart on Geographic comparison
Exhibits104: Data Table on Geographic comparison
Exhibits105: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits106: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits107: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits108: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits109: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits110: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits111: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits112: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits113: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits114: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits115: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits116: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits117: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits118: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits119: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits120: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits121: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits122: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits123: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits124: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits125: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits126: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits127: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits128: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits129: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits130: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits131: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits132: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits133: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits134: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits135: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits136: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits137: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits138: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits139: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits140: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits141: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits142: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits143: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits144: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits145: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits146: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits147: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits148: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits149: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits150: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits151: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits152: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits153: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits154: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits155: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits156: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits157: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits158: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits159: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits160: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits161: Market opportunity By Geographical Landscape ($ million)
Exhibits162: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits163: Impact of drivers and challenges in 2024 and 2029
Exhibits164: Overview on criticality of inputs and factors of differentiation
Exhibits165: Overview on factors of disruption
Exhibits166: Impact of key risks on business
Exhibits167: Companies covered
Exhibits168: Company ranking index
Exhibits169: Matrix on companies position and classification
Exhibits170: Abbott Laboratories - Overview
Exhibits171: Abbott Laboratories - Business segments
Exhibits172: Abbott Laboratories - Key news
Exhibits173: Abbott Laboratories - Key offerings
Exhibits174: Abbott Laboratories - Segment focus
Exhibits175: SWOT
Exhibits176: Acer Therapeutics Inc. - Overview
Exhibits177: Acer Therapeutics Inc. - Product / Service
Exhibits178: Acer Therapeutics Inc. - Key offerings
Exhibits179: SWOT
Exhibits180: Arcturus Therapeutics Holdings Inc. - Overview
Exhibits181: Arcturus Therapeutics Holdings Inc. - Product / Service
Exhibits182: Arcturus Therapeutics Holdings Inc. - Key offerings
Exhibits183: SWOT
Exhibits184: Bausch Health Companies Inc. - Overview
Exhibits185: Bausch Health Companies Inc. - Business segments
Exhibits186: Bausch Health Companies Inc. - Key news
Exhibits187: Bausch Health Companies Inc. - Key offerings
Exhibits188: Bausch Health Companies Inc. - Segment focus
Exhibits189: SWOT
Exhibits190: Boehringer Ingelheim International GmbH - Overview
Exhibits191: Boehringer Ingelheim International GmbH - Product / Service
Exhibits192: Boehringer Ingelheim International GmbH - Key news
Exhibits193: Boehringer Ingelheim International GmbH - Key offerings
Exhibits194: SWOT
Exhibits195: CAMP4 - Overview
Exhibits196: CAMP4 - Product / Service
Exhibits197: CAMP4 - Key offerings
Exhibits198: SWOT
Exhibits199: Eurocept B.V. - Overview
Exhibits200: Eurocept B.V. - Product / Service

Exhib

Have a question?

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Christine Sirois

Manager - Americas

+1-860-674-8796

SEE OUR FAQ